IperionX Limited (NASDAQ:IPX - Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 23,800 shares, a decline of 17.6% from the February 29th total of 28,900 shares. Based on an average trading volume of 39,400 shares, the days-to-cover ratio is presently 0.6 days.
IperionX Stock Performance
NASDAQ:IPX traded up $0.42 during trading hours on Friday, reaching $14.91. The company had a trading volume of 49,229 shares, compared to its average volume of 31,879. The business's 50-day simple moving average is $13.76 and its two-hundred day simple moving average is $10.81. IperionX has a twelve month low of $4.99 and a twelve month high of $18.57. The company has a current ratio of 8.97, a quick ratio of 7.74 and a debt-to-equity ratio of 0.04.
Institutional Trading of IperionX
An institutional investor recently raised its position in IperionX stock. Stifel Financial Corp raised its holdings in shares of IperionX Limited (NASDAQ:IPX - Free Report) by 111.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 255,251 shares of the company's stock after purchasing an additional 134,289 shares during the quarter. Stifel Financial Corp owned 1.12% of IperionX worth $2,364,000 as of its most recent SEC filing. Institutional investors own 2.76% of the company's stock.
About IperionX
(
Get Free Report)
IperionX’s mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries including space, aerospace, electric vehicles and 3D printing. IperionX’s breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, 100% recyclable, have low carbon intensity and to do so at product qualities that meet or exceed current industry standards.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IperionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.
While IperionX currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
